BMS 6078 (Metaglip 5 mg / 500 mg)
Generic Name: glipizide/metformin
Pill with imprint BMS 6078 is Pink, Elliptical / Oval and has been identified as Metaglip 5 mg / 500 mg. It is supplied by Bristol-Myers Squibb.
Metaglip is used in the treatment of diabetes, type 2 and belongs to the drug class antidiabetic combinations. Risk cannot be ruled out during pregnancy. Metaglip 5 mg / 500 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for BMS 6078
Metaglip
- Generic Name:
- glipizide/metformin
- Imprint:
- BMS 6078
- Strength:
- 5 mg / 500 mg
- Color:
- Pink
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Antidiabetic combinations
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- Not a controlled drug
- Labeler / Supplier:
- Bristol-Myers Squibb
More about Metaglip (glipizide / metformin)
- Metaglip Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- En Español
- Drug class: antidiabetic combinations
Consumer resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
